Literature DB >> 11904018

New trends in neuromodulation for the management of neuropathic pain.

Kenneth M Aló1, Jan Holsheimer.   

Abstract

Since its first application in 1967, the methodology and technology of spinal cord stimulation for the management of chronic, intractable pain have evolved continuously. Despite these developments and improved knowledge of the effects of spinal anatomy and epidural contact configuration on paresthesia coverage, the clinical results of spinal cord stimulation-particularly the long-term effects-are still unsatisfactory in many patients. This dissatisfaction has come primarily from the failure of single-electrode configurations to provide consistent paresthesia coverage of the entire painful area. Therefore, new approaches were developed during the late 1990s that attempted to selectively cover one or more dermatomes with paresthesia as well as to provide sequential stimulation of different anatomic sites. These approaches have been applied both intraspinally and extraspinally by stimulating either the spinal nerves or the dorsal columns. To target parts of the latter, different methods have been developed and tested using either two-dimensional contact configurations or electronic field steering. These developments hold promise for improving long-term outcomes as well as increasing the number of pain conditions that can be treated with neuromodulation therapy. In this review, the history, theoretical basis, and evolution of these methodologies, as well as the ways in which they represent new trends in neuromodulation, are discussed.

Entities:  

Mesh:

Year:  2002        PMID: 11904018     DOI: 10.1097/00006123-200204000-00003

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  23 in total

1.  Tissue and electrode capacitance reduce neural activation volumes during deep brain stimulation.

Authors:  Christopher R Butson; Cameron C McIntyre
Journal:  Clin Neurophysiol       Date:  2005-10       Impact factor: 3.708

Review 2.  Sacral nerve stimulation: neuromodulation for voiding dysfunction and pain.

Authors:  Robert D Mayer; Fred M Howard
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

3.  Current steering to control the volume of tissue activated during deep brain stimulation.

Authors:  Christopher R Butson; Cameron C McIntyre
Journal:  Brain Stimul       Date:  2008-01       Impact factor: 8.955

4.  Comparison of spinal cord stimulation profiles from intra- and extradural electrode arrangements by finite element modelling.

Authors:  Qiujun Huang; Hiroyuki Oya; Oliver E Flouty; Chandan G Reddy; Matthew A Howard; George T Gillies; Marcel Utz
Journal:  Med Biol Eng Comput       Date:  2014-04-27       Impact factor: 2.602

5.  Engaging Cervical Spinal Cord Networks to Reenable Volitional Control of Hand Function in Tetraplegic Patients.

Authors:  Daniel C Lu; V Reggie Edgerton; Morteza Modaber; Nicholas AuYong; Erika Morikawa; Sharon Zdunowski; Melanie E Sarino; Majid Sarrafzadeh; Marc R Nuwer; Roland R Roy; Yury Gerasimenko
Journal:  Neurorehabil Neural Repair       Date:  2016-05-18       Impact factor: 3.919

6.  Sacral nerve stimulation for treatment of chronic intractable anorectal pain -a case report-.

Authors:  Kyung Seung Yang; Young Hoon Kim; Hue Jung Park; Min Hye Lee; Dong Hee Kim; Dong Eon Moon
Journal:  Korean J Pain       Date:  2010-03-10

7.  Spinal cord stimulation as a treatment for refractory neuropathic pain in tethered cord syndrome: a case report.

Authors:  Maarten Moens; Ann De Smedt; Jan D'Haese; Steven Droogmans; Cristo Chaskis
Journal:  J Med Case Rep       Date:  2010-02-25

8.  Spinal cord stimulation for neuropathic pain: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-03-01

Review 9.  Peripheral nerve stimulation for neuropathic pain.

Authors:  Konstantin V Slavin
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

10.  Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain.

Authors:  Nasim Zabihi; Arthur Mourtzinos; Mary Grey Maher; Shlomo Raz; Larissa V Rodríguez
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.